Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2854049rdf:typepubmed:Citationlld:pubmed
pubmed-article:2854049lifeskim:mentionsumls-concept:C0025266lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C0332307lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C0007412lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C1704632lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C0871261lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C0574032lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C2911692lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C1706817lld:lifeskim
pubmed-article:2854049lifeskim:mentionsumls-concept:C0205463lld:lifeskim
pubmed-article:2854049pubmed:dateCreated1989-5-26lld:pubmed
pubmed-article:2854049pubmed:abstractTextTo determine whether there are basic biological differences between Type A and Type B men, we compared hemodynamic, electrophysiologic and neuroendocrine responses to equipotent doses of isoproterenol (ISO) and norepinephrine (NE) in 10 Type A and 10 Type B men ages 18 to 29. Results showed equal hemodynamic and neuroendocrine responses to graded ISO doses in Type A and Type B individuals. In contrast, Type A men showed a more prolonged decrease in electrocardiographic T-wave amplitude (TWA) than did Type B men. Post hoc analyses of the correlates of TWA recovery during high-dose ISO infusion provide preliminary evidence for a more robust parasympathetic antagonism of sympathetic nervous system effects in Type B men, especially those with low scores on the Cook-Medley Ho scale. These findings suggest that, in addition to cognitively mediated increases in sympathetic nervous system reactivity, Type As may also be placed at increased risk of developing coronary heart disease by reduced levels of parasympathetic antagonism of sympathetic effects.lld:pubmed
pubmed-article:2854049pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:languageenglld:pubmed
pubmed-article:2854049pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:citationSubsetIMlld:pubmed
pubmed-article:2854049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2854049pubmed:statusMEDLINElld:pubmed
pubmed-article:2854049pubmed:issn0278-6133lld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:LaneJ DJDlld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:SchanbergS...lld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:SuzukiJJlld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:KuhnC MCMlld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:MuranakaMMlld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:WilliamsR...lld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:AndersonN BNBlld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:McCownNNlld:pubmed
pubmed-article:2854049pubmed:authorpubmed-author:MonouHHlld:pubmed
pubmed-article:2854049pubmed:issnTypePrintlld:pubmed
pubmed-article:2854049pubmed:volume7 Suppllld:pubmed
pubmed-article:2854049pubmed:ownerNLMlld:pubmed
pubmed-article:2854049pubmed:authorsCompleteYlld:pubmed
pubmed-article:2854049pubmed:pagination145-63lld:pubmed
pubmed-article:2854049pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:meshHeadingpubmed-meshheading:2854049-...lld:pubmed
pubmed-article:2854049pubmed:year1988lld:pubmed
pubmed-article:2854049pubmed:articleTitlePhysiological responses to catecholamine infusions in type A and type B men.lld:pubmed
pubmed-article:2854049pubmed:affiliationDepartment of Psychosomatic Medicine, Tohoku University School of Medicine.lld:pubmed
pubmed-article:2854049pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:2854049pubmed:publicationTypeComparative Studylld:pubmed
pubmed-article:2854049pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:2854049pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:2854049lld:pubmed